Sensodyne
GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m
British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.
Sensodyne Toothpaste-Maker Haleon Planning Job Cuts - The Guardian
Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Gu...
Advertisement
Copyright © 2024. All rights reserved. Developed by Square1 and powered by PublisherPlus.com